Quick Facts at a Glance
- Recall Date
- August 27, 2025
- Hazard Level
- HIGH
- Brands
- Zydus Lifesciences, Zydus Pharmaceuticals USA Inc., Succinylcholine Chloride Injection
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 3 states
- At-Risk Groups
- GENERAL, PREGNANT, PETS
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- Zydus Lifesciences, Zydus Pharmaceuticals USA Inc., Succinylcholine Chloride Injection
- Product type
- Intravenous injection vial
- Model numbers
- L400077, L400113, L400372, L400373, L400374
- UPC codes
- 70710-1377, 70710-1377-1, 70710-1377-2
- Sizes
- 10 mL
- Sold at
- Multiple Retailers
- Where affected
- MS, OH, LA
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
August 27, 2025
Reported by FDA DRUG
September 17, 2025
RecallRadar source check
April 18, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: Letter
About This Product
Succinylcholine Chloride Injection is a sterile, prescription neuromuscular blocker used in anesthesia. It is distributed by Zydus Pharmaceuticals USA Inc. in the U.S. Market.
Why This Is Dangerous
Out-of-Specification impurities or degradation products could compromise drug safety and patient outcomes.
Industry Context
This recall is not described as part of a broader industry pattern in the provided data.
Practical Guidance
How to identify if yours is affected
- Verify lot numbers on your packaging against recall notices.
- Isolate affected stock and discontinue use.
Where to find product info
NDC numbers on vial label and carton; recall notification letters to healthcare facilities.
What timeline to expect
Remedy processing timelines are not specified in the notice.
If the manufacturer is unresponsive
- Escalate to hospital risk management or seek guidance from distributor.
- Document all communications and stock movements.
How to prevent similar issues
- Implement or review supplier recall procedures.
- Use lot-level tracking and reservation of critical IV drugs.
- Confirm FDA or manufacturer updates for remediation steps.
Documentation advice
Keep recall letters, inventory counts, and replacement records.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Brand: Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL). Packaging: 10 mL multi-dose vials, sterile. Manufactured by Zydus Lifesciences Ltd, Vadodara, India. Distributed by Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534. NDC 70710-1377-1 (vial), 70710-1377-2 (carton). Quantity: 270,125 vials. Sold/distributed in MS, OH, LA, and Puerto Rico.
Reported Incidents
No injury or incident counts are provided in the notice.
Key Facts
- Active recall as of 2025-08-27 (recall date)
- High hazard level
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.